These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
    Author: Iwasa S, Yanagawa T, Fan J, Katoh R.
    Journal: Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431.
    Abstract:
    BACKGROUND: Stromal cell-derived factor (SDF)-1 and CXCR4 form an important chemokine ligand/receptor pair. Recent studies suggest that CXCR4 is expressed in certain cancer cells, and malignant cells use this chemokine/receptor system to promote tumor progression and metastasis. However, the pathophysiological significance of their expression in gastric cancer tissue has not been fully elucidated. PATIENTS AND METHODS: SDF-1 and CXCR4 expression levels in gastric cancer specimens obtained from 124 patients were examined by immunohistochemistry. RESULTS: The staining intensity of CXCR4 and SDF-1 in cancer cells was significantly higher in intestinal-type than in diffuse-type gastric cancer. There was a significant correlation between the expression of CXCR4 and SDF-1 and liver metastasis and lymphatic metastasis in the intestinal-type cancer; however, this correlation was not found in the diffuse-type cancer. Furthermore, intestinal-type cancer cells that permeated the vascular or lymphatic channels as well as liver and lymph node metastases showed strong CXCR4 and SDF-1 staining. CONCLUSION: The overexpressed CXCR4 and SDF-1 in intestinal-type cancer cells may be therapeutic targets for preventing lymphatic and hematogenous metastasis.
    [Abstract] [Full Text] [Related] [New Search]